FINWIRES · TerminalLIVE
FINWIRES

EcoGraf Confirms HF-free Process Is Competitive at $478 Per Tonne Across Global Battery Manufacturing Hubs

By

EcoGraf's (ASX:EGR) assessment of its patented hydrofluoric acid-free (HFfree) process technology for the production of high-purity active anode material confirmed strong cost competitiveness across all seven potential locations assessed across major global battery manufacturing hubs, according to a Friday Australian bourse filing.

The company said the average purification operating cost is about $478 per tonne of spherical purified graphite (SPG), with an integrated supply chain delivering an estimated cost of about $1,441 per tonne, positioning EcoGraf as a competitive alternative to the Chinese supply.

EcoGraf has secured grant funding totaling about AU$10 million to support development activities, it added.

Related Articles

Asia

Tamboran Resources Completes Acquisition of Oil, Gas Company

Tamboran Resources (ASX:TBN) completed the acquisition of Falcon Oil & Gas through the acquisition of its subsidiaries after the receipt of final approval from the Supreme Court of British Columbia, according to a Friday filing with the Australian bourse.The company now holds roughly 2.8 million net prospective acres, the filing said.The company issued about 6.5 million shares of common stock to eligible Falcon shareholders on completion of the transaction, per the filing.

$ASX:TBN
Asia

Market Chatter: Toyota Halts Development of Lexus Next-Gen EV, Shifts Focus to SUVs Amid Weakening Global Demand

Toyota Motor (TYO:7203) will halt development of a mass-production version of the Lexus LF-ZC sedan, a next-generation electric vehicle originally intended to utilize advanced gigacasting technology, Nikkei Asia reported on Friday.The automaker is pivoting toward SUVs and other models as EV sales slow worldwide, with production initially scheduled for late this year but then delayed to mid-2027 at a plant in Aichi Prefecture, the news agency said.Despite Toyota's global EV sales rising 42% in 2025 to over 190,000 units-boosted by the revamped bZ4X SUV and the China-only bZ3X-the broader market now faces significant challenges, the publication said.These include the Trump administration's removal of EV purchase tax incentives and the European Union's reversal of its planned 2035 ban on new internal combustion engine vehicles, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$TYO:7203
Asia

Cynata Says WHO Selects Generic Name for Cymerus Mesenchymal Stem Cells

Cynata Therapeutics (ASX:CYP) said the World Health Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.The generic name represents the active agent in iPSC-derived MSC products.

$ASX:CYP